Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Gosol Energy Group AB | GOSOL | Dec 27, 2024 | 0.99 | +3.90 |
Greater Than | GREAT | Dec 27, 2024 | 27.50 | 0.00 |
Green Landscaping Group | GREEN | Dec 27, 2024 | 70.40 | -1.12 |
Greenmerc | GMERCB | Dec 27, 2024 | 6.92 | -1.14 |
Gruvaktiebolaget Viscaria | VISC | Dec 27, 2024 | 21.30 | +0.47 |
Gränges | GRNG | Dec 27, 2024 | 132.00 | +2.01 |
Grängesberg Exploration Holding | GRANGX | Dec 27, 2024 | 10.38 | -4.07 |
Guard Therapeutics International | GUARD | Dec 27, 2024 | 20.00 | -3.85 |
Guideline Geo | GGEO | Dec 27, 2024 | 8.30 | +4.27 |
Gullberg & Jansson | GJAB | Dec 27, 2024 | 14.70 | -1.67 |
H&D Wireless Sweden Holding B | HDWB | Dec 27, 2024 | 0.00 | -10.53 |
H&M B | HMB | Dec 27, 2024 | 149.05 | +0.03 |
HAKI Safety A | HAKIA | Dec 27, 2024 | 26.00 | 0.00 |
HAKI Safety B | HAKIB | Dec 27, 2024 | 23.80 | +2.15 |
Hamlet BioPharma AB (publ) | HAMLETB | Dec 27, 2024 | 3.80 | -2.81 |
Hansa Biopharma | HNSA | Dec 27, 2024 | 40.50 | +8.00 |
Hanza AB | HANZA | Dec 27, 2024 | 77.00 | +2.39 |
Harm Reduction Group | NOHARM | Dec 27, 2024 | 0.03 | +3.94 |
Havsfrun Investment | HAVS | Dec 27, 2024 | 12.45 | -1.19 |
Havsfrun Investment B | HAVB | Dec 27, 2024 | 12.45 | -1.19 |
Haypp Group | HAYPP | Dec 27, 2024 | 60.40 | -0.66 |
Headsent | VIMAB | Dec 27, 2024 | 10.90 | +4.81 |
Heba B | HEBAB | Dec 27, 2024 | 32.65 | +1.56 |
Hedera Group | HEGR | Dec 27, 2024 | 3.80 | +33.80 |
Heimstaden Pref | HEIMPREF | Dec 27, 2024 | 15.50 | +0.52 |
Heliospectra | HELIO | Dec 27, 2024 | 0.39 | -2.50 |
Hemnet Group | HEM | Dec 27, 2024 | 339.40 | +1.43 |
Hemply Balance | HMPLY | Dec 27, 2024 | 0.04 | +10.26 |
Hernö Gin B | HERNOB | Dec 27, 2024 | 3.45 | -4.83 |
Hexagon B | HEXAB | Dec 27, 2024 | 106.10 | +0.38 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.